Cumberland Pharmaceuticals Inc (CPIX) stock
CPIXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/30
$5.88−0.75 (-11.31%)
Close on Nov 13, 2026Market cap $88.10MP/E 1.3Yield –
Cumberland Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Cumberland Pharmaceuticals's operating cash flow for the twelve months ending Sep 30, 2026 was -$939.23K, down 113.7% year over year. For fiscal 2025 it was $4.93M. Over ten years it grew -1.7% a year on average. The highest annual figure on record is $8.72M in fiscal 2011.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.93M | – |
| FY2024 | Dec 31, 2024 | -$612.19K | -110.0% |
| FY2023 | Dec 31, 2023 | $6.09M | -27.9% |
| FY2022 | Dec 31, 2022 | $8.45M | +33.3% |
| FY2021 | Dec 31, 2021 | $6.34M | +17.1% |
| FY2020 | Dec 31, 2020 | $5.42M | +77.2% |
| FY2019 | Dec 31, 2019 | $3.06M | -1.8% |
| FY2018 | Dec 31, 2018 | $3.11M | – |
| FY2017 | Dec 31, 2017 | -$557.71K | -197.9% |
| FY2016 | Dec 31, 2016 | $569.48K | -90.3% |
| FY2015 | Dec 31, 2015 | $5.88M | -12.2% |
| FY2014 | Dec 31, 2014 | $6.69M | +797.1% |
| FY2013 | Dec 31, 2013 | $746.13K | -89.5% |
| FY2012 | Dec 31, 2012 | $7.14M | -18.2% |
| FY2011 | Dec 31, 2011 | $8.72M | +2416.0% |
| FY2010 | Dec 31, 2010 | $346.66K | -14.4% |
| FY2009 | Dec 31, 2009 | $404.97K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$1.50M | -900.3% |
| Q2 FY2026 | Jun 30, 2026 | $168.74K | -80.0% |
| Q1 FY2026 | Mar 31, 2026 | $387.03K | -90.1% |
| Q4 FY2025 | Dec 31, 2025 | $3.03K | -99.8% |
| Q3 FY2025 | Sep 30, 2025 | $187.18K | -60.6% |
| Q2 FY2025 | Jun 30, 2025 | $843.80K | – |
| Q1 FY2025 | Mar 31, 2025 | $3.90M | – |
| Q4 FY2024 | Dec 31, 2024 | $1.90M | +83.1% |
| Q3 FY2024 | Sep 30, 2024 | $475.50K | -61.5% |
| Q2 FY2024 | Jun 30, 2024 | -$855.66K | -116.3% |
| Q1 FY2024 | Mar 31, 2024 | -$2.14M | – |
| Q4 FY2023 | Dec 31, 2023 | $1.04M | -71.4% |
| Q3 FY2023 | Sep 30, 2023 | $1.24M | -53.1% |
| Q2 FY2023 | Jun 30, 2023 | $5.24M | +124.6% |
| Q1 FY2023 | Mar 31, 2023 | -$1.42M | – |
| Q4 FY2022 | Dec 31, 2022 | $3.64M | +85.6% |
| Q3 FY2022 | Sep 30, 2022 | $2.64M | – |
| Q2 FY2022 | Jun 30, 2022 | $2.33M | -13.7% |
| Q1 FY2022 | Mar 31, 2022 | -$150.50K | -108.4% |
| Q4 FY2021 | Dec 31, 2021 | $1.96M | +129.5% |
| Q3 FY2021 | Sep 30, 2021 | -$102.01K | -111.9% |
| Q2 FY2021 | Jun 30, 2021 | $2.70M | -4.1% |
| Q1 FY2021 | Mar 31, 2021 | $1.79M | +101.0% |
| Q4 FY2020 | Dec 31, 2020 | $853.92K | -0.4% |
| Q3 FY2020 | Sep 30, 2020 | $857.07K | +16.7% |
| Q2 FY2020 | Jun 30, 2020 | $2.82M | +52.1% |
| Q1 FY2020 | Mar 31, 2020 | $888.54K | – |
| Q4 FY2019 | Dec 31, 2019 | $857.00K | -77.0% |
| Q3 FY2019 | Sep 30, 2019 | $734.43K | – |
| Q2 FY2019 | Jun 30, 2019 | $1.85M | +133.1% |
| Q1 FY2019 | Mar 31, 2019 | -$385.73K | -263.7% |
| Q4 FY2018 | Dec 31, 2018 | $3.72M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.64M | -265.2% |
| Q2 FY2018 | Jun 30, 2018 | $794.09K | – |
| Q1 FY2018 | Mar 31, 2018 | $235.59K | -83.6% |
| Q4 FY2017 | Dec 31, 2017 | -$459.56K | -156.1% |
| Q3 FY2017 | Sep 30, 2017 | $992.84K | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.53M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.44M | – |
| Q4 FY2016 | Dec 31, 2016 | $819.79K | – |
See a number that looks wrong?